Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment

Journal of Veterinary Pharmacology and Therapeutics
Lena OlsénHans Tjälve

Abstract

The pharmacokinetics and the effects on inhibition of histamine-induced cutaneous wheal formation of the histamine H1-antagonist fexofenadine were studied in horse. The effect of ivermectin pretreatment on the pharmacokinetics of fexofenadine was also examined. After intravenous infusion of fexofenadine at 0.7 mg/kg bw the mean terminal half-life was 2.4 h (range: 2.0-2.7 h), the apparent volume of distribution 0.8 L/kg (0.5-0.9 L/kg), and the total body clearance 0.8 L/h/kg (0.6-1.2 L/h/kg). After oral administration of fexofenadine at 10 mg/kg bw bioavailability was 2.6% (1.9-2.9%). Ivermectin pretreatment (0.2 mg/kg, p.o.) 12 h before oral fexofenadine decreased the bioavailability to 1.5% (1.4-2.1%). In addition, the area under the plasma concentration-time curve decreased 27%. Ivermectin did not affect the pharmacokinetics of i.v. administered fexofenadine. Ivermectin may influence fexofenadine absorption by interfering in intestinal efflux and influx pumps, such as P-glycoprotein and the organic anion transport polypeptide family. Oral and i.v. fexofenadine significantly decreased histamine-induced wheal formation, with a maximal duration of 6 h. A pharmacokinetic/pharmacodynamic link model indicated that fexofenadine in ...Continue Reading

References

Mar 1, 1986·Journal of Veterinary Pharmacology and Therapeutics·A MorrowK P Baker
Apr 1, 1995·The Veterinary Clinics of North America. Equine Practice·W S Rosenkrantz
Sep 1, 1996·Anti-cancer Drugs·A Didier, F Loor
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·L Z BenetV J Wacher
Mar 10, 2001·Clinical Pharmacology and Therapeutics·M A HammanS D Hall
Aug 15, 2001·Clinical Pharmacology and Therapeutics·R B KimG R Wilkinson
Sep 29, 2001·Advanced Drug Delivery Reviews·L Z Benet, C L Cummins
May 23, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Céline M LaffontAlain Bousquet-Mélou
Nov 5, 2002·Journal of Clinical Pharmacology·Michael D PerloffDavid J Greenblatt
Feb 13, 2003·British Journal of Clinical Pharmacology·Christer TannergrenHans Lennernäs
Apr 2, 2003·Journal of Veterinary Pharmacology and Therapeutics·K TörnekeH Broström
Oct 31, 2003·Clinical Pharmacology and Therapeutics·Christer TannergrenHans Lennernäs
Nov 12, 2003·The Journal of Pharmacology and Experimental Therapeutics·Takashi NozawaIkumi Tamai
Jul 1, 1985·Parasitology Today·W C Campbell
Nov 16, 2004·Toxicology and Applied Pharmacology·Eva TydénHans Tjälve
Dec 1, 2004·Journal of Pharmaceutical Sciences·Amrita V KamathSaeho Chong
Dec 17, 2004·Journal of Veterinary Pharmacology and Therapeutics·P L Toutain, P Lees
Jan 4, 2005·European Journal of Pharmacology·Raymond F OrzechowskiCathryn A Valancius
Jan 8, 2005·Clinical Pharmacology and Therapeutics·Norio Yasui-FurukoriTomonori Tateishi
Apr 12, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Harunobu TaharaYuichi Sugiyama

❮ Previous
Next ❯

Citations

Aug 13, 2011·European Journal of Drug Metabolism and Pharmacokinetics·Evren GundogduErcument Karasulu
Nov 13, 2012·Critical Reviews in Biomedical Engineering·Hoi-Kei LonWilliam J Jusko
Apr 25, 2012·International Journal of Pharmaceutics·Fu QiangHyo-Kyung Han
Aug 6, 2010·International Journal of Pharmaceutics·Hong-Mei PiaoDae-Duk Kim
Feb 13, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yeamin HuhDae-Duk Kim
Jun 22, 2007·The Veterinary Journal·Lena OlsénCarina Ingvast-Larsson
Aug 4, 2009·Journal of Veterinary Pharmacology and Therapeutics·T Grabowski, J J Jaroszewski
May 3, 2007·Journal of Veterinary Pharmacology and Therapeutics·L OlsénP Larsson
Jun 13, 2018·Journal of Veterinary Pharmacology and Therapeutics·Laura MorenoLuis I Álvarez
Feb 10, 2018·Current Medicinal Chemistry·Guillermo VirkelAdrián Lifschitz
Jun 28, 2019·American Journal of Veterinary Research·Taisuke KurodaYoshinori Kasashima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Related Papers

Journal of Veterinary Pharmacology and Therapeutics
K TörnekeH Broström
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Fu QiangHyo-Kyung Han
Journal of Veterinary Pharmacology and Therapeutics
Lena OlsénP Larsson
© 2021 Meta ULC. All rights reserved